Kirk W. Kerr joined the Abbott Nutrition’s Health Economics and Outcomes Research team in June 2019. While at Abbott, Kirk has researched the impact of nutrition on patients in inpatient, outpatient, and surgical care settings. Prior to joining Abbott, Kirk worked in the FDA’s Center for Drug Evaluation and Research researching the impact of FDA policies on drug development, drug prices, and patient access to medicines. He also provided economic support for FDA’s Generic Drug User Fee (GDUFA) and Biosimilar User Fee (BsUFA) negotiating teams. Kirk has a PhD and MA in Economics from Ohio State University, and BS and MA in Economics from the University of Missouri.
Remote speaker / Presenting virtually
Malnutrition in pediatric intensive care units (PICUs) when left unrecognized and untreatedcan lead to prolonged and costly hospitalizations. We examined malnutrition diagnosis rates and its burden by assessing clinical patient outcomes among a large cohort of critically ill pediatric patients at an academic medical center. Our findings highlight the importance of optimizing malnutrition screening, diagnosis, and treatment protocols to ensure malnutrition is addressed promptly in the inpatient setting.